HIV Drugs Sector: Growth Drivers and Challenges
Growth Drivers
-
Surging Cases of Cancer Worldwide
- Rising Initiatives by the Governments
Challenges
-
Lack of Awareness Regarding the Treatment
HIV Drugs Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.1% |
|
Base Year Market Size (2024) |
USD 36.72 billion |
|
Forecast Year Market Size (2037) |
USD 79.29 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of HIV drugs is estimated at USD 38.62 billion.
HIV Drugs Market size was valued at USD 36.72 billion in 2024 and is likely to cross USD 79.29 billion by 2037, expanding at more than 6.1% CAGR during the forecast period i.e., between 2025-2037.
North America industry is anticipated to account for largest revenue share by 2037, on the back of presence of an ultra-modern healthcare system.
The major players in the market are F. Hoffmann-La Roche Ltd, Cipla Inc., Teva Pharmaceuticals Industries Ltd. and Janssen Global Services, LLC.
